Apellis Pharmaceuticals, Inc. (APLS): 25-NSE filed May 14, 2026

Form type

25-NSE

Filing date

May 14, 2026

Accession number

0001354457-26-000449

Filer

Apellis Pharmaceuticals, Inc. (CIK 1492422)